期刊文献+

先天性体肺分流心脏病合并肺动脉高压患者的手术适应证评估进展 被引量:1

Progress in Evaluation of Patients with Left to Right Shunt Congenital Heart Disease and Pulmonary Hypertension
下载PDF
导出
摘要 先天性体肺分流性心脏病可导致肺循环持续的血流量增加、肺血管收缩和肺血管重构,引起肺动脉压力升高,影响手术治疗的效果。在肺血管病变尚可逆时,手术后患者肺动脉压力下降,预后良好;当肺血管病变严重,手术后肺动脉压力持续升高,预后不良。如何准确判断先天性心脏病合并肺动脉高压患者的手术适应证仍有争议,国内外临床医生和基础研究学者都对先天性体肺分流心脏病合并肺动脉高压患者的手术适应证评估进行了深入研究,对此进行总结综述。 Left to right shunt congenital heart disease results in a consistent increase of blood in puhnonary vascular bed, thus leading to the constriction and remodeling of pulmonary vasculature and an increased pulmonary pressure, which may affect the surgical effect of pa- tients. At early stage, pulmonary vascular disease is still reversible, which guarantees a good prognosis of patients. However, when the pul- monary vascular disease becomes severe, surgical treatment can not benefit patients and may even lead to a higher mortality. The severity and reversibility of pulmonary vasculature is not correlated with the pulmonary resistance or the pulmonary pressure. How to select patients for surgeries remains a clinical controversy confronted with many doctors. This review will provides the latest progress in basic and clinical re- searches to determine the operative indications for selecting patients with pulmonary hypertension associated with congenital heart disease for surgical treatment.
出处 《心血管病学进展》 CAS 2013年第1期59-62,共4页 Advances in Cardiovascular Diseases
关键词 先天性心脏病 左向右分流 肺动脉高压 可逆性 手术指征 congenital heart disease left to right shunt pulmonary hypertension reversibility operative indication
  • 相关文献

参考文献24

  • 1McLaughlin VV,Archer SL,Badesch DB. ACCF/AHA 2009 expert consensus document on pulmonary hypertension:a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association:developed in collaboration with the American College of Chest Physicians,American Thoracic Society,Inc.,and the Pulmonary Hypertension Association[J].Circulation,2009,(16):2250-2294.doi:10.1161/CIRCULATIONAHA.109.192230.
  • 2Adatia I,Kothari SS,Feinstein JA. Pulmonary hypertension associated withcongenital heart disease:pulmonary vascular disease:the global perspective[J].Chest,2010,(6 suppl):52S-61S.
  • 3Beghetti M,Tissot C. Pulmonary arterial hypertension in congenital heart diseases[J].Seminars in Respiratory and Critical Care Medicine,2009,(04):421-428.doi:10.1055/s-0029-1233311.
  • 4Rabinovitch M,Keane JF,Norwood WI. Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects[J].Circulation,1984,(04):655-667.
  • 5Viswanathan S,Kumar RK. Assessment of operability of congenital cardiacshunts with increased pulmonary vascular resistance[J].Catheter CardiovascInterv,2008,(05):665-670.
  • 6Warnes CA,Williams RG,Bashore TM. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease).Developed in Collaboration With the American Society of Echocardiography,Heart Rhythm Society,International S[J].Journal of the American College of Cardiology,2008,(23):e143-e263.
  • 7Baumgartner H,Bonhoeffer P,de Groot NM. ESC guidelines for themanagement of grown-up congenital heart disease(new version 2010)[J].European Heart Journal,2010,(23):2915-2957.
  • 8小儿先天性心脏病相关性肺高压诊断和治疗(专家共识)[J].中华小儿外科杂志,2011,32(4):306-318. 被引量:35
  • 9无,朱鲜阳.常见先天性心脏病介入治疗中国专家共识 一、房间隔缺损介入治疗[J].介入放射学杂志,2011,20(1):3-9. 被引量:171
  • 10Lopes AA,O' Leary PW. Measurement,interpretation and use of hemodynamic parameters in pulmonary hypertension associated with congenital heart disease[J].Cardiology in the Young,2009,(05):431-435.

二级参考文献28

  • 1Singh TP,Rohit M,Grover A,菅鑫妍.口服西地那非疗法治疗严重肺动脉高压的效果研究[J].中国处方药,2006(8):29-29. 被引量:49
  • 2Barst RJ,Langleben D,Badesch D,菅鑫妍.使用选择性内皮素A受体拮抗剂sitaxsentan治疗肺动脉高压[J].中国处方药,2006,5(8):29-29. 被引量:38
  • 3Berger RM. Possibilities and impossibilities in the evaluation of pulmonary vascular disease in congenital heart defects, gur Heart J, 2000, 21:17-27.
  • 4Yamaki S, Horiuchi T, Ishizawa E, et. al. Indication for total correction of complete transposition of the great arteries with pulmonary hypertension. J thorac Cardiovasc Surg, 1980,79: 890-895.
  • 5Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med, 2004, 351: 1655-1665.
  • 6Ichinose F, Roberts JD Jr, Zapol WM. Inhaled nitric oxide:a selective pulmonary vasodilator., current uses and therapeutic potential. Circulation, 2004,109 : 3106-3111.
  • 7Opitz CF, Wensel R, Bettmann M, et al. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation. Eur Heart J, 2003, 24: 356-365.
  • 8Costa EL,Jardin C,Bogossian HB, et al. Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria. Vascul Pharmaeol, 2005, 43: 143-147.
  • 9Baylor P. Lack of agreement between thermodilution and tick methods in the measurement of cardiac output. J Intensive Care Med, 2006,21 : 93-98.
  • 10Pearl RG, Siegel LC. Therrnodilution cardiac output measurement with a large left-to-right shunt. J Clin Monit , 1991, 7: 146-153.

共引文献221

同被引文献14

  • 1Hjortdal VE, Redington AN,De leval MR, et al. Hybrid approaches to complex congenital cardiac surgery[J]. European journal of cardio-thoracic surgery., official journal of the European Association for Cardio-thoracic Surgery,2002,22(6) :885- 890.
  • 2Hu R, Zhang H, Dong W, et al. Transventricular valvot omy {or pulmonary atresia with intact ventricular sep- turn in neonates..a single centre experience in mid term follow-up[J]. European journal of cardio thoracic sur-gery: official journal of the European Association for Cardio thoracic Surgery,2015,47(1) =168-172.
  • 3Kim YH. Pulmonary valvotomy with echocardiographic guidance in neonates with pulmonary atresia and intact ventricular septum[J]. Catheterization and cardiovascu- lar interventions:official journal of the Society for Car diac Angiography Interventions, 2015,85 (4) : E123- E128.
  • 4任卫东,常才.法洛四联症[M]//朱永胜.超声诊断学.北京:人民卫生出版社,2013:108-111.
  • 5Zhang B, Liang J, Zheng X, et al. Transcatheter closure of postoperative residual ventricular septal defects using Amplatzer type perimembranous VSD oceluders [J]. The Journal of invasive cardiology, 2013,25 (8) : 402- 405.
  • 6Maheshwari S,Suresh PV,Bansal M,et al. Perventricu- lar device closure of muscular ventricular septal defects on the beating heart[J]. Indian Heart Journal, 2004, 56(4) : 333-335.
  • 7Mo X,Zuo W,Ma Zet al. Hybrid procedure with car diopulmonary bypass for muscular ventricular septal defects in children[J]. European journal of cardio-tho- racic surgery: official journal of the European Associa- tion for Cardio thoracic Surgery, 2011,40(5):1 203-1 206.
  • 8Pedra CA,Pedra SR,Chaccur P,et al. Perventricular de- vice closure of congenital muscular ventricular septal de{ects[J]. Expert review of cardiovascular therapy, 2010,8(5) .-663 -674.
  • 9左思阳,闫瑞玲,李丽梅,郑英.彩色多普勒对室间隔缺损术后残余分流的预后评估[J].中国临床医学影像杂志,2008,19(7):508-509. 被引量:1
  • 10杨剑,杨丽芳,刘金成,俞世强,左健,金振晓,陈涛,易定华,张军,李军.室间隔缺损和动脉导管未闭合并中重度肺动脉高压的分期复合治疗[J].中华心血管病杂志,2011,39(2):128-131. 被引量:6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部